Today: 19 April 2026
BT share price today: BT Group stock climbs as Openreach widens copper switch push
19 January 2026
1 min read

BT share price today: BT Group stock climbs as Openreach widens copper switch push

London, Jan 19, 2026, 11:04 GMT — Regular session

  • BT.A rose about 1.7%, reaching near 182 pence in mid-morning London trading
  • An industry report reveals Openreach has expanded its “stop sell” fibre migration programme by 132 exchanges.
  • All eyes are on BT’s trading update scheduled for Feb. 5

BT Group plc shares edged up about 1.7% to 182.05 pence in London by 1104 GMT, recovering after slipping to 178.10 earlier. The stock had ended the previous session at 178.95.

The move came after European stocks fell, triggered by U.S. President Donald Trump’s threat to slap tariffs on European nations if they reject U.S. control over Greenland—a jolt to risk appetite. “This is reintroducing a trade war dynamic that markets had started to price out,” said Kyle Rodda, senior financial market analyst at Capital.com. Reuters

UK telecom investors have been watching the gradual move from copper lines to fibre upgrades. On Monday, ThinkBroadband revealed that Openreach added 132 exchanges to its “stop sell” list, now impacting about 12.5 million properties. James Lilley, Openreach’s Managed Customer Migrations Director, described the stop sell effort as “a vital step in accelerating the UK’s transition to a modern full fibre future.” thinkbroadband

This move is a key piece of a broader strategy to retire the ageing copper-based Public Switched Telephone Network (PSTN), the analogue system that supports traditional landline calls. Openreach plans to shut down the analogue network by 31 January 2027, pushing most customers to migrate to digital phone services running over the internet.

BT chief executive Allison Kirkby highlighted the fibre upgrade as a key part of a renewed UK-focused strategy, designed to reduce cash flow pressure once the heavy investment phase ends. In November, BT confirmed it is still on course to reach 25 million fibre-enabled premises by December 2026. The company also reaffirmed its target of generating £2 billion in free cash flow by March 2027, despite increasing broadband competition.

Peers crept up too. Vodafone’s stock rose about 1.1%, hitting 101.95 pence by late morning.

The switch doesn’t come easy. Ofcom has emphasized its aim to shield customers from needless disruption or harm as the move to digital landlines unfolds. This means tight rules on emergency calls and protections during power outages—a clear sign that any service glitches or delays could invite sharp regulatory and political attention.

BT is set to release its quarterly update soon. The company’s calendar pins the Q3 FY26 trading update for Feb. 5, followed by an interim dividend payment on Feb. 11. Investors will be watching for details on broadband line trends, fibre rollout progress, and cash flow.

Stock Market Today

  • Brown-Forman (BF.B) Faces Valuation Debate After Strong Short-Term Rally
    April 18, 2026, 9:26 PM EDT. Brown-Forman's (BF.B) stock surged about 27% in one month, reversing last year's roughly 11% decline. The recent sharp rebound contrasts with a weaker long-term trend, highlighting momentum shifts. Despite shares trading near analyst price targets at $29.15, fair value estimates diverge widely. Simply Wall St's discounted cash flow (DCF) model values Brown-Forman at $37.78, suggesting undervaluation, while another model pegs fair value at $21.00, indicating the stock is roughly 39% overvalued. The gap reflects differing views on declining global alcohol consumption due to rising health awareness, which could pressure Brown-Forman's revenue growth. However, premium spirits and emerging market demand might offset some risks. Investors face critical decisions amid mixed signals, weighing whether current prices embed growth prospects or overestimate future earnings.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
JTC share price slips as SocGen flags 8.9% stake in Permira takeover trade
Previous Story

JTC share price slips as SocGen flags 8.9% stake in Permira takeover trade

Pennon Group share price jumps even as FTSE 250 dips — dividend and March update in focus
Next Story

Pennon Group share price jumps even as FTSE 250 dips — dividend and March update in focus

Go toTop